Approaches to Characterize Biased Agonists in Early Phase Drug Development

Time: 2:45 pm
day: Day Two

Details:

  • Reviewing the literature and rationale behind bias signaling in GPCR research and development
  • Detailing methods used to illuminate bias in downstream pathways
  • Linking signaling bias to different physiological outcomes

Speakers: